NPI: 1225199128 · BURNSVILLE, MN 55337 · Clinical Medical Laboratory · NPI assigned 12/13/2006
Authorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
| Authorized Official | RING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL) |
| NPI Enumeration Date | 12/13/2006 |
Other providers sharing the same authorized official: RING, MAUREEN
| Provider | City | State | Total Paid |
|---|---|---|---|
| FAIRVIEW HEALTH SERVICES | MINNEAPOLIS | MN | $90.41M |
| FAIRVIEW HEALTH SERVICES | SAINT PAUL | MN | $48.52M |
| FAIRVIEW HEALTH SERVICES | BURNSVILLE | MN | $29.98M |
| FAIRVIEW HEALTH SERVICES | MINNEAPOLIS | MN | $26.56M |
| HEALTHEAST ST. JOHN'S HOSPITAL | MAPLEWOOD | MN | $17.91M |
| FAIRVIEW HEALTH SERVICES | EDINA | MN | $17.24M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | SAINT PAUL | MN | $11.37M |
| FAIRVIEW CLINICS | BLOOMINGTON | MN | $9.40M |
| FAIRVIEW HEALTH SERVICES | PRINCETON | MN | $9.36M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | SAINT PAUL | MN | $8.76M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | SAINT PAUL | MN | $8.29M |
| FAIRVIEW CLINICS | BROOKLYN PARK | MN | $8.06M |
| FAIRVIEW HEALTH SERVICES | WYOMING | MN | $7.71M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | MAPLEWOOD | MN | $7.44M |
| HEALTHEAST WOODWINDS HOSPITAL | WOODBURY | MN | $6.17M |
| FAIRVIEW CLINICS | BURNSVILLE | MN | $4.75M |
| FAIRVIEW CLINICS | MINNEAPOLIS | MN | $4.75M |
| FAIRVIEW EXPRESS CARE | SAINT PAUL | MN | $4.57M |
| FAIRVIEW CLINICS | SAINT PAUL | MN | $4.37M |
| HEALTHEAST MEDICAL RESEARCH INSTITUTE | WOODBURY | MN | $4.07M |
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 1,539 | $120K |
| 2021 | 4,963 | $168K |
| 2022 | 6,585 | $221K |
| 2023 | 4,486 | $151K |
| 2024 | 581 | $23K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8,177 | 2,348 | $537K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6,751 | 1,531 | $77K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,506 | 300 | $60K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 195 | 186 | $6K |
| 36415 | Collection of venous blood by venipuncture | 853 | 479 | $2K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 411 | 231 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | 159 | 103 | $787.74 |
| 85027 | 102 | 59 | $396.94 |